This record was last updated June 4, 2024 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
A multicenter, randomized, controlled clinical study comparing the efficacy and safety of allogeneic hematopoietic stem cell transplantation with decitabine-Fludarabine- busulfan (Dec-FB4) and Fludarabine-busulfan (FB4) as pretreatment regimens for the treatment of acute myeloid leukemia in adults with MR gene abnormalities
Protocol Amendment History
3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-03-01; most recent amendment 2024-06-02.